深圳市华生元基因工程发展有限公司欢迎您

研究动态Research

重组人表皮生长因子在羟基磷灰石义眼胎植入术中的应用

发布时间:2006-10-13 00:00 点击:374 字号:

重组人表皮生长因子在羟基磷灰石义眼胎植入术中的应用
刘懿  刘德成  刘凤霞
作者单位:450006 郑州市第七人民医院眼科
电话:0371-68856534
 
【摘要】  目的   观察重组人表皮生长因子(rhEGF)对羟基磷灰石(hydroxyapatite,HA)义眼胎植入的作用及效果。方法 本组病例59例。羟基磷灰石义眼胎植入术后用rhEGF滴眼液结膜囊内滴眼每日4次。结果 51例Ⅰ期愈合,8例前部球结膜及筋膜愈合不良,其中6例自行愈合,2例更换眼胎后愈合。结论  rhEGF滴眼液对羟基磷灰石义眼胎植入术后早期的纤维血管化具有促进作用,从而预防羟基磷灰石义眼胎暴露的发生。
【关键词】 重组人表皮生长因子;羟基磷灰石,义眼胎植入术
 
 
Use of rhEGF in hydroxyapatite orbital implantation   Liu Yi ,Liu Decheng, Liu Fengxia.   Department of Ophthalmology, The 7th People’s Hospital of Zhengzhou city, Zhengzhou 450006, China
Abstract  Objective  To observe the effect of recombinant human epidermal growth factor(rhEFGF) in hydroxyapatite(HA) orbital implantation. Methods  59 cases were included in this study. The rhEGF eye drops was used 4 times 1 day after operation. Results  51 cased healed by first intention, 5 cases healed by delayed intention and 2 healed after changed orbit implants.  Conclusion  rhEGF eye drops can improve fibro neovascularization after HA orbital implantation and prevent HA exposure.
Key words recombinant human epidermal growth factor;   Hydroxyapatite, Orbital implant